Business Description
Thalia Therapeutics Plc is a UK-based pharmaceutical company focused on improving how cancer treatments and vaccines reach and act on cells. The company has developed a range of therapeutic platforms, including delivery systems for genetic materials and a compound targeting inflammatory bowel disease. Founded in 1979 and headquartered in Chellaston, the company rebranded from N4 Pharma Plc in March 2026.
